about
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cellsThe cell surface mucin podocalyxin regulates collective breast tumor budding.Identification and expression profiling of blood-brain barrier membrane proteins.PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.Genome wide analysis of novel copy number variations duplications/deletions of different epileptic patients in Saudi Arabia.Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem CellsPodocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Podocalyxin regulates astrocytoma cell invasion and survival against temozolomideRole of podocalyxin in astrocytoma: Clinicopathological and in vitro evidenceIsolation of glioma cancer stem cells in relation to histological grades in glioma specimens.Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen.Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancerPodocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2
P2860
Q24653465-5E4FD4F2-E79E-4919-89AB-ED6A2F6548ABQ27338644-262B3876-E729-499D-827A-A75CCDBF655DQ33515413-A21C82F0-9997-4FDD-9434-4AF61CE0FDD6Q33600992-CEA4910A-690C-452B-A5D4-C9F1A435348DQ35022551-F229DBD6-8990-4F04-AAE9-0FB43A78D825Q35042553-0C7C2205-BF31-4046-A9C7-3CC9F36AD19EQ35053495-1A22AAE9-D44F-4618-955B-89F9C47AB7CFQ35287580-BAB57670-7E6A-4CEA-8C69-2E2946F2170FQ36756141-B6477D82-FF8E-4227-A91A-02A37BC43677Q37375238-1A8837A3-01F2-4DD3-A6FE-F4BEC0DD2710Q37735632-FB0FD48A-B8D5-4ECE-A8F2-02068A1240F6Q38259585-3FB86504-D065-497B-91D8-24E1E2605F93Q39081304-EF42F28C-1956-48B0-A1BB-FDEC1218BA1CQ39873210-7CD02CAE-1DC9-4C81-9A43-24FC5BA1C7E9Q41790462-F5D07777-ED43-4497-8DB8-DDC8A4A470EFQ45073630-CDBAB519-EFC6-4B15-9B08-A6349A2D1344Q47694823-9CDFEA3A-E58D-4383-A431-D4F0CAE38719Q47860795-C834D8EA-1A94-4543-9AC3-2460C1F4894BQ53324484-B0B62669-FB67-4276-8CCF-010F3D9AB457Q55249763-727C8B92-9E52-4B10-8FFA-7A2565BE1B27Q57112164-AF901D64-CC7E-417D-B93A-A33F75ACDC43Q58797407-572044F9-763A-4DF5-A45A-8F521CCA6207
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Podocalyxin expression in malignant astrocytic tumors.
@en
Podocalyxin expression in malignant astrocytic tumors.
@nl
type
label
Podocalyxin expression in malignant astrocytic tumors.
@en
Podocalyxin expression in malignant astrocytic tumors.
@nl
prefLabel
Podocalyxin expression in malignant astrocytic tumors.
@en
Podocalyxin expression in malignant astrocytic tumors.
@nl
P2093
P1476
Podocalyxin expression in malignant astrocytic tumors
@en
P2093
Janet E Price
Kazuhiko Mishima
Masao Matsutani
Mika Kato Kaneko
Norihito Hayatsu
Ryo Nishikawa
P304
P356
10.1016/J.BBRC.2008.07.049
P407
P577
2008-07-17T00:00:00Z